By expenditures
| Name | Title | Type |
|---|---|---|
| Kyle Miller | Director | Auditee |
| Dr. David Pecha | Executive Vice President | Auditee |
| Jim Hinkle | Managing Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 388429 | 2025 | 2026-02-21 | FORVIS MAZARS LLP | $13.46M |
| 342631 | 2024 | 2025-02-15 | Forvis Mazars LLP | $12.20M |
| 303907 | 2023 | 2024-04-18 | Hinkle & Company PC | $12.02M |
| 54404 | 2022 | 2023-03-29 | Hinkle & Company PC | $15.79M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 388429 | 2025 | 2026-02-21 | 1174860 | 2025-003 | Material Weakness | Yes | L |
| 388429 | 2025 | 2026-02-21 | 1174859 | 2025-003 | Material Weakness | Yes | L |
| 388429 | 2025 | 2026-02-21 | 1174858 | 2025-002 | Material Weakness | Yes | N |
| 388429 | 2025 | 2026-02-21 | 1174857 | 2025-002 | Material Weakness | Yes | N |
| 342631 | 2024 | 2025-02-15 | 1099787 | 2024-003 | Significant Deficiency | - | N |
| 342631 | 2024 | 2025-02-15 | 1099786 | 2024-003 | Significant Deficiency | - | N |
| 342631 | 2024 | 2025-02-15 | 1099785 | 2024-002 | Significant Deficiency | - | N |
| 342631 | 2024 | 2025-02-15 | 1099784 | 2024-002 | Significant Deficiency | - | N |
| 342631 | 2024 | 2025-02-15 | 523345 | 2024-003 | Significant Deficiency | - | N |
| 342631 | 2024 | 2025-02-15 | 523344 | 2024-003 | Significant Deficiency | - | N |
| 342631 | 2024 | 2025-02-15 | 523343 | 2024-002 | Significant Deficiency | - | N |
| 342631 | 2024 | 2025-02-15 | 523342 | 2024-002 | Significant Deficiency | - | N |